Press Release

Catalent Plans Multi-Phase, $100 Million Expansion of Italian Facility to Increase Biologics Manufacturing Capabilities in Europe

SOMERSET, N.J. — Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products, today announced that it will commence the first phase of a planned $100 million expansion program at its facility in Anagni, Italy, to add biologics drug substance manufacturing capabilities, supporting the growing European market …

Catalent Plans Multi-Phase, $100 Million Expansion of Italian Facility to Increase Biologics Manufacturing Capabilities in Europe Read More »

CPhI Japan celebrates return, as cell & gene therapies and digital innovation highlighted

Tokyo 27th April 2021: CPhI Japan, the first large pharma event to trade in 2021, played host to 7214 attendees at the exhibition and a further 7204 virtual users from across the globe.  The event, a key marker for the strength of the regional industry, has rebounded quickly with some 216 exhibitors searching for pharma partners. In …

CPhI Japan celebrates return, as cell & gene therapies and digital innovation highlighted Read More »

Syngenta and Botanical Solution Inc. (BSI) team up for a new botanical-based biofungicde rollout !

Davis, CA: Botanical Solution Inc. (BSI) and Syngenta, two companies which are closely aligned in their commitment to innovation and sustainability in agriculture, announce that they have reached an agreement to commercialize BSI’s first product in Peru and Mexico. The two companies have already commercialized successfully the product in Chile under the trade name BotristopÒ. This biofungicide …

Syngenta and Botanical Solution Inc. (BSI) team up for a new botanical-based biofungicde rollout ! Read More »

Inria and InSilicoTrials partner up on a European project leveraging simulation for cardiac devices and drugs

Inria Sophia Antipolis Méditerranée is leading SimCardioTest, a new EU project funded with 8 million Euros that will provide  insight into designing new predictive tools in cardiac pathologies. Among the ten partners, the rising startup InSilicoTrials. The search for new drugs and devices is particularly difficult in the case of cardiovascular disease, which remains the …

Inria and InSilicoTrials partner up on a European project leveraging simulation for cardiac devices and drugs Read More »

Pleio and Medisafe Showcase Human-to-Digital Patient Engagement Future

New program combines human hello to digital embrace for long-term medication support Boston, MA – Medisafe, a leading digital drug companion company, is teaming up with Pleio to launch a new integrated digital health model with a unique combination of human and digital resources. Known as the GoodStart program, Pleio’s concierge service uses mentors to acclimate patients on …

Pleio and Medisafe Showcase Human-to-Digital Patient Engagement Future Read More »

Botanical Solution Inc. (BSI) Secures $3.3 Million in Funding with Second Round Planned for Spring 2021

Davis, CA: Botanical Solution Inc. (BSI), innovator of sustainable, highly consistent and cost effective Advanced Botanical Materials, has successfully secured $3.3 million in a seed round of funding, and is planning another round of funding for Spring 2021. The Spring 2021 Round of funding will boost BSI’s proven ability to discover and develop novel botanical products that …

Botanical Solution Inc. (BSI) Secures $3.3 Million in Funding with Second Round Planned for Spring 2021 Read More »

COVID-19 winter lockdowns & national restrictions drive demand for ‘body and mind’ formulations say SIRIO Europe

Manufacturers seeking CDMOs that can quickly develop complex formulations offering both body and mind benefits  SIRIO Europe (Ayanda) – the European nutraceutical and pharmaceutical contract development and manufacturing organisation (CDMO) and member of SIRIO Group – forecasts a winter surge in requests from nutra brands for new ‘dual benefit’ mood enhancing formulations as a result of COVID-19 measures. The …

COVID-19 winter lockdowns & national restrictions drive demand for ‘body and mind’ formulations say SIRIO Europe Read More »

Vectura signs agreement to support the development of VR588 to treat asthma

Chippenham, UK: Vectura Group plc, an industry leading inhalation CDMO, today announces that it has signed a global out licence and development agreement with Kinaset Therapeutics Inc. for the development and commercialisation of VR588, a preclinical novel inhaled pan-JAK inhibitor for the prevention and treatment of severe asthma. Pan-JAK inhibitors have been developed and tested …

Vectura signs agreement to support the development of VR588 to treat asthma Read More »

UCB taps Medisafe in development of digital companion to support patient engagement

Medisafe, a leading digital therapeutics company specializing in digital companions, has been selected by UCB to develop branded digital drug companions for its antiepileptic medications, with greater capabilities to expand across additional brands. The digital companions streamline support for patients to access financial assistance, patient diaries, and doctor discussion guides throughout their treatment journey. UCB …

UCB taps Medisafe in development of digital companion to support patient engagement Read More »

Leading digital health conference Frontiers Health 2020 in partnership with Healthware witnesses the global acceleration of digital health

Frontiers Health, held on November 12-13th, kicks off globally with a comprehensive agenda of 60+ sessions by 200 top speakers dedicated to the most relevant topics in digital health innovation, including over 100 start-ups and scale-ups that made it through the selection process. An overarching theme of the event will be exploring how digital health …

Leading digital health conference Frontiers Health 2020 in partnership with Healthware witnesses the global acceleration of digital health Read More »

Cognitive function boosted in MCI patients, with new ketogenic drink

New clinical research conducted by the University of Sherbrooke, Canada, published in Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association, has established people with Mild Cognitive Impairment (MCI) experienced significant improvement in cognitive function when consuming a specialized ketogenic drink (BrainXpert Energy Complex) twice a day for six months. Affecting 15-20% of people aged 65+, MCI …

Cognitive function boosted in MCI patients, with new ketogenic drink Read More »

NanoViricides Nominates a Novel Candidate for COVID-19 Treatment

NanoViricides, Inc. (NYSE American:NNVC) (the “Company”) a global leader in the development of highly effective antiviral therapies based on a novel nanomedicines platform, today announced that it has nominated a clinical drug candidate for the treatment of COVID-19, thus further advancing its COVID-19 program closer to human clinical trials. The Company has accelerated its drug …

NanoViricides Nominates a Novel Candidate for COVID-19 Treatment Read More »

CCAHPS Home Health Top 5 Report: the newest feature in our complete survey program (ebook)

Turn CAHPS data into better performance and optimized patient care. Download the ebook. The Consumer Assessment of Healthcare Providers and Systems (CAHPS®) Home Health Care Survey (also known as HHCAHPS) was created to measure the patient experience within Medicare-certified home health agencies—but it’s more than just another CMS requirement. With the trend toward value-based purchasing, …

CCAHPS Home Health Top 5 Report: the newest feature in our complete survey program (ebook) Read More »